Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07012863 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Life-saving Treatment With Dry-plasma for Massive Bleeding in an Pre-hospital Setting

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jun 30, 2026 to Jun 30, 2027
    • Study completion date: Sep 30, 2026 to Sep 30, 2027
    • Eligibility criteria shortened, about 1 word
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The overall goal of this clinical trial is to study how prehospital transfused dry plasma affect outcomes in terms of mortality as well as complications and coagulation status of patients in or about to develop bleeding shock. Researchers will compare dry plasma to standard care to see if dry plasma improves survival compared to crystalloid fluid in prehospital patients with heavy bleeding.
Trial Details
NCT Number NCT07012863
Lead Sponsor Vastra Gotaland Region
Conditions
(from sponsor)		 Bleeding, Aortic Rupture, Gastrointestinal Hemorrhage, Obstetric Bleeding, Blunt Injury, Penetrating Injury
Related terms Aortic Rupture, Gastrointestinal Hemorrhage, Hemorrhage, Wounds, Nonpenetrating, Wounds, Penetrating
Enrollment 650 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov